171 related articles for article (PubMed ID: 20877355)
1. Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours.
White DE; Burchill SA
Br J Cancer; 2010 Oct; 103(9):1380-90. PubMed ID: 20877355
[TBL] [Abstract][Full Text] [Related]
2. p38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death.
Myatt SS; Redfern CP; Burchill SA
Clin Cancer Res; 2005 Apr; 11(8):3136-48. PubMed ID: 15837770
[TBL] [Abstract][Full Text] [Related]
3. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
Myatt SS; Burchill SA
Oncogene; 2008 Feb; 27(7):985-96. PubMed ID: 17700534
[TBL] [Abstract][Full Text] [Related]
4. BAY 11-7082 induces cell death through NF-kappaB-independent mechanisms in the Ewing's sarcoma family of tumours.
White DE; Burchill SA
Cancer Lett; 2008 Sep; 268(2):212-24. PubMed ID: 18471963
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous role of the glutathione antioxidant system in modulating the response of ESFT to fenretinide in normoxia and hypoxia.
Magwere T; Burchill SA
PLoS One; 2011; 6(12):e28558. PubMed ID: 22174837
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL).
Van Valen F; Fulda S; Truckenbrod B; Eckervogt V; Sonnemann J; Hillmann A; Rödl R; Hoffmann C; Winkelmann W; Schäfer L; Dockhorn-Dworniczak B; Wessel T; Boos J; Debatin KM; Jürgens H
Int J Cancer; 2000 Oct; 88(2):252-9. PubMed ID: 11004677
[TBL] [Abstract][Full Text] [Related]
7. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
[TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor-induced cell death is effected through sustained activation of p38MAPK and up-regulation of the death receptor p75NTR.
Williamson AJ; Dibling BC; Boyne JR; Selby P; Burchill SA
J Biol Chem; 2004 Nov; 279(46):47912-28. PubMed ID: 15310753
[TBL] [Abstract][Full Text] [Related]
9. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
Sessler T; Healy S; Samali A; Szegezdi E
Pharmacol Ther; 2013 Nov; 140(2):186-99. PubMed ID: 23845861
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells.
Sonnemann J; Dreyer L; Hartwig M; Palani CD; Hong le TT; Klier U; Bröker B; Völker U; Beck JF
J Cancer Res Clin Oncol; 2007 Nov; 133(11):847-58. PubMed ID: 17486365
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity.
Lissat A; Vraetz T; Tsokos M; Klein R; Braun M; Koutelia N; Fisch P; Romero ME; Long L; Noellke P; Mackall CL; Niemeyer CM; Kontny U
Am J Pathol; 2007 Jun; 170(6):1917-30. PubMed ID: 17525260
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells.
Abdollahi T; Robertson NM; Abdollahi A; Litwack G
Apoptosis; 2005 Dec; 10(6):1383-93. PubMed ID: 16215677
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 sensitizes TNF-α and TRAIL/Apo2L dependent cell death through upregulation of death receptors in human cancer cells.
Sano E; Kazaana A; Tadakuma H; Takei T; Yoshimura S; Hanashima Y; Ozawa Y; Yoshino A; Suzuki Y; Ueda T
Biochim Biophys Acta Mol Cell Res; 2021 Jun; 1868(7):119037. PubMed ID: 33839168
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
16. Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin.
García-Santos G; Martin V; Rodríguez-Blanco J; Herrera F; Casado-Zapico S; Sánchez-Sánchez AM; Antolín I; Rodríguez C
Br J Cancer; 2012 Mar; 106(7):1288-96. PubMed ID: 22382690
[TBL] [Abstract][Full Text] [Related]
17. p-Hydroxylcinnamaldehyde from cochinchinamomordica seed reverses resistance to TRAIL in human oesophageal squamous cell carcinoma via the activation of the p38 mitogen-activated protein kinase signalling pathway.
Ma M; Zhang C; Xiang XH; Deng XQ; Dai SL; Wei SS; Zhang XM; Zhao LM; Liu YJ; Shan BE
Biomed Pharmacother; 2020 Jan; 121():109611. PubMed ID: 31731196
[TBL] [Abstract][Full Text] [Related]
18. Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines.
Kouhara J; Yoshida T; Nakata S; Horinaka M; Wakada M; Ueda Y; Yamagishi H; Sakai T
Int J Oncol; 2007 Mar; 30(3):679-87. PubMed ID: 17273769
[TBL] [Abstract][Full Text] [Related]
19. p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.
Ganeshan VR; Schor NF
Cancer Chemother Pharmacol; 2014 Feb; 73(2):271-9. PubMed ID: 24253178
[TBL] [Abstract][Full Text] [Related]
20. 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.
Anding AL; Jones JD; Newton MA; Curley RW; Clagett-Dame M
Anticancer Res; 2018 Aug; 38(8):4403-4416. PubMed ID: 30061204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]